Confotherapeutics.com Recently Analyzed

Home » Confotherapeutics.com

Confotherapeutics.com has a Worldwide ranking of n/a Down n/a and ranking n/a in n/a. Using IP address 107.178.253.32 in and found 0 Other Websites on this Server

The site's up time is: 77 ms

Domain Age: 5 years, 19 days (Creation Date: 2014-05-27)

Similar Webs


Check the markup (HTML, XHTML,...) of Confotherapeutics.com

Validate Now

  • Domain: Confotherapeutics.com
  • Hostname: 32.253.178.107.bc.googleusercontent.com
  • Name Servers:

    1: ns3.european-server.com

    2: ns4.european-server.com

  • Email Abuse:

    No Emails

  • Continent Code: NA
  • Country Code: US
  • Country Code3: USA
  • Country Name: United States
  • Region: CA
  • City: Mountain View
  • Postal Code: 94043
  • Latitude: 37.419200897217
  • Longitude: -122.05740356445
  • Dma Code: 807
  • Area Code: 650

Analyzed Recently

  › Rdrecipe.com (1 seconds ago)

  › Ubdajudge.com (8 seconds ago)

  › Vision3architects.com (1 seconds ago)

  › Borntorundogs.com (1 seconds ago)

  › Rtvtoros.com (2 seconds ago)

  › Confotherapeutics.com (1 seconds ago)

  › Tappairsoft.com (3 seconds ago)

  › Pbornsteinlaw.com (2 seconds ago)

  › Retraite-a-maurice.com (5 seconds ago)

  › Appsdealer.com (1 seconds ago)

  › Gamecoinshop.com (5 seconds ago)

  › Drdonwood.com (1 seconds ago)

  › F-photos.com (1 seconds ago)

  › Realitatevirtuala.com (0 seconds ago)

  › Sizzleproductions.com (3 seconds ago)

  › Crossfitinitiative.com (1 seconds ago)

  › M-shika.com (2 seconds ago)

  › Deteller.com (6 seconds ago)

  › Stchrisindy.org (4 seconds ago)

  › Universalsleeve.com (3 seconds ago)

Keywords Suggestions

  › Confo therapeutics
  › Confo therapeutics nv
  › Confo therapeutics crunchbase

MetaTags & Keyword Analysis

Websites Listing Results

Confotherapeutics.com search for results as listed below with the link list and email address for this website

Confo Therapeutics - Exploiting

Confo Therapeutics employs its proprietary CONFO® technology to lock inherently unstable functional conformations of GPCRs as a superior starting point for drug discovery. Confob

Link: http://confotherapeutics.com/ (Actived: Monday Jun 10, 2019)

Confo Therapeutics | LinkedIn

About us. Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists.

Link: https://www.linkedin.com/company/confo-therapeutics (Actived: Saturday Jun 8, 2019)

Confo Therapeutics | Crunchbase

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO® technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery.

Link: https://www.crunchbase.com/organization/confo-therapeutics (Actived: Sunday Jun 9, 2019)

Confo Therapeutics: Private Company Information - Bloomberg

Confo Therapeutics is a drug discovery company building internal drug discovery programs on G-protein coupled receptors (GPCRs) addressing unmet medical need. The company was founded in 2015 and

Link: https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=324783624 (Actived: Thursday Jun 6, 2019)

Confo Therapeutics Enters Into Drug Discovery ...

Confo Therapeutics, an emerging drug discovery company, announced today that it has entered into a research collaboration and license agreement with Roche for the discovery, development and

Link: https://www.prnewswire.com/news-releases/confo-therapeutics-enters-into-drug-discovery-collaboration-with-roche-665111713.html (Actived: Tuesday Dec 19, 2017)

Confo Therapeutics | VentureRadar

"Confo Therapeutics is a drug discovery company building a portfolio of first-in-class programs based on its proprietary Confo® technology, using antibody fragments or "Confobodies" to lock inherently unstable functional conformations of GPCRs as a superior starting point for drug discovery.

Link: https://www.ventureradar.com/organisation/Confo%20Therapeutics/e90e1bfd-a9f9-409c-9df4-da022a1ed21c (Actived: Wednesday May 29, 2019)

Confo Therapeutics Appoints Frank Landolt as its Chief ...

GHENT, Belgium--(BUSINESS WIRE)--Confo Therapeutics, an emerging drug discovery company, today announces the appointment of Frank Landolt as its Chief Counsel Legal & IP, effective from 1 January

Link: https://www.businesswire.com/news/home/20181206005088/en/Confo-Therapeutics-Appoints-Frank-Landolt-Chief-Counsel (Actived: Wednesday Dec 5, 2018)

Confo Therapeutics Raises €30 Million in Series A ...

GHENT, Belgium--(BUSINESS WIRE)-- Confo Therapeutics, an emerging drug discovery company, today announces the completion of a €30 million ($33.4 million) Series A financing.The investment was led by BioGeneration Ventures (BGV) and co-led by Wellington Partners, with the addition of new investors Fund+ and Perceptive Advisors.

Link: https://www.biospace.com/article/releases/confo-therapeutics-raises-30-million-in-series-a-financing/ (Actived: Tuesday May 7, 2019)

SpringWorks Therapeutics

At SpringWorks Therapeutics, we see the groundbreaking potential in that science. We see what it could mean for people without options, without treatments, and without hope. Unfortunately, we also see that sometimes, that science is overlooked, de-prioritized and unfulfilled, unable to make its full impact.

Link: https://www.springworkstx.com/ (Actived: Tuesday Jun 11, 2019)